Literature DB >> 3366936

Immunoturbidimetric assays for serum apolipoproteins A1 and B using Cobas Bio centrifugal analyser.

J N Mount1, E M Kearney, M Rosseneu, B M Slavin.   

Abstract

Immunoturbidimetric assays for measuring the apolipoproteins A1 and B using the Cobas Bio centrifugal analyser are described. The methods were specific, offered good sensitivity (less than 0.05 g/l) and intrabatch variability, with coefficients of variation between 2.4% and 3.5%, and were cost effective. Reference ranges were calculated for a group of civil servants, aged 35 to 55 years.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3366936      PMCID： PMC1141480          DOI： 10.1136/jcp.41.4.471

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  5 in total

1.  Nephelometry of apolipoprotein B in human serum.

Authors:  C C Heuck; G Schlierf
Journal:  Clin Chem       Date:  1979-02       Impact factor: 8.327

2.  Is the ratio of apo B/apo A-I an early predictor of coronary atherosclerosis?

Authors:  W A Van Stiphout; A Hofman; H A Kruijssen; R Vermeeren; P H Groot
Journal:  Atherosclerosis       Date:  1986-11       Impact factor: 5.162

3.  Standardization of immunoassays for the quantitation of plasma Apo B protein.

Authors:  M Rosseneu; N Vinaimont; R Vercaemst; W Dekeersgieter; F Belpaire
Journal:  Anal Biochem       Date:  1981-09-01       Impact factor: 3.365

4.  Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease.

Authors:  A Noma; T Yokosuka; K Kitamura
Journal:  Atherosclerosis       Date:  1983-10       Impact factor: 5.162

5.  Quantitative determination of human plasma apolipoprotein A-I by laser immunonephelometry.

Authors:  M Rosseneu; R Vercaemst; N Vinaimont; P Van Tornout; L O Henderson; P N Herbert
Journal:  Clin Chem       Date:  1981-06       Impact factor: 8.327
  5 in total
  14 in total

1.  Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men.

Authors:  J W Swan; C Walton; I F Godsland; D Crook; M F Oliver; J C Stevenson
Journal:  Br Heart J       Date:  1994-01

2.  Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients.

Authors:  J C Mazurkiewicz; G F Watts; F G Warburton; B M Slavin; C Lowy; E Koukkou
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

3.  Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer.

Authors:  Z Chen; A Keech; R Collins; B Slavin; J Chen; T C Campbell; R Peto
Journal:  BMJ       Date:  1993-04-03

4.  Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia.

Authors:  G F Watts; E M Kearney; N A Taub; B M Slavin
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

5.  One year experience in the treatment of familial hypercholesterolaemia with simvastatin.

Authors:  J Quiney; G F Watts; M Kerr-Muir; B Slavin; B Lewis
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

6.  Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.

Authors:  S Chhabra; R Narang; R Lakshmy; S Vasisht; D P Agarwal; L M Srivastava; S C Manchanda; N Das
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

7.  Insulin resistance syndrome in postmenopausal women with cardiological syndrome X.

Authors:  I F Godsland; D Crook; J C Stevenson; P Collins; G M Rosano; B Lees; M Sidhu; P A Poole-Wilson
Journal:  Br Heart J       Date:  1995-07

8.  Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in type IIa hypercholesterolemia.

Authors:  D Crook; R Bruce; M Worthington; D Mulcahy; D Patterson; V Wynn
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727

9.  Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.

Authors:  Philippa J Talmud; Fotios Drenos; Sonia Shah; Tina Shah; Jutta Palmen; Claudio Verzilli; Tom R Gaunt; Jacky Pallas; Ruth Lovering; Kawah Li; Juan Pablo Casas; Reecha Sofat; Meena Kumari; Santiago Rodriguez; Toby Johnson; Stephen J Newhouse; Anna Dominiczak; Nilesh J Samani; Mark Caulfield; Peter Sever; Alice Stanton; Denis C Shields; Sandosh Padmanabhan; Olle Melander; Claire Hastie; Christian Delles; Shah Ebrahim; Michael G Marmot; George Davey Smith; Debbie A Lawlor; Patricia B Munroe; Ian N Day; Mika Kivimaki; John Whittaker; Steve E Humphries; Aroon D Hingorani
Journal:  Am J Hum Genet       Date:  2009-11       Impact factor: 11.025

10.  Comparison of immunoturbidimetric and Lowry methods for measuring concentration of very low density lipoprotein apolipoprotein B-100 in plasma.

Authors:  M H Cummings; G F Watts; P J Lumb; B M Slavin
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.